Menu

Vascular Biogenics Ltd. VBLT

Full chart Compare
Set alert

Price alert · VBLT

All alert types
0.16 +0.16

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Expenses: $634.00KExpenses → Selling, General & Admin: $11.75MExpenses → Research & Development: $21.65MExpenses → Interest Expense: $85.00KGross Profit → Expenses: $554.00KRevenue → Gross Profit: $554.00KRevenue → Cost of Revenue: $104.00KNet Loss → Expenses: $32.30MOther Income$634.00KGross Profit$554.00KNet Loss$32.30MCost of Revenue$104.00KExpenses$33.49MSelling, General & Admin$11.75MResearch & Development$21.65MInterest Expense$85.00KRevenue$658.00K

Latest period ending Dec 31, 2022 · select a line to chart its full history

VBLT annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
658.00K768.00K922.00K562.00K585.00K
554.00K403.00K528.00K340.00K330.00K
-32.85M-30.00M-24.48M-20.08M-21.25M
-32.30M-29.92M-24.23M-19.40M-20.50M
0.420.450.550.540.62
VBLT annual balance sheet
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
18.02M21.99M13.18M9.44M29.35M
29.66M64.66M41.71M49.01M60.68M
7.21M12.48M10.79M12.98M7.58M
564.00K2.35M2.53M2.94M796.00K
22.45M50.58M30.92M36.02M53.09M
VBLT annual cash flow
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
-31.59M-24.98M-23.38M-13.09M-15.68M
27.30M-15.49M9.89M-6.10M24.73M
22.00K49.11M17.07M-359.00K13.67M
-812.00K-1.47M-51.00K-73.00K-2.23M
-4.28M8.64M3.58M-19.55M22.72M